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Abstract 30 
Skeletal muscle is an insulin sensitive tissue and accounts for approximately 80% of 31 
post-prandial glucose disposal. This study describes the effects of insulin, delivered 32 
for 72 hours, to skeletal muscle myoblasts during differentiation or to skeletal muscle 33 
myotubes. After chronic treatment, cultures were acutely stimulated with insulin and 34 
analysed for total and phosphorylated Akt (Ser473), mRNA expression of metabolic 35 
and myogenic markers and insulin-stimulated glucose uptake. Skeletal muscle cells 36 
differentiated in the presence of insulin chronically, reduced acute insulin stimulated 37 
phosphorylation of Akt Ser473. In addition, there was a reduction in mRNA expression 38 
of Hexokinase II (HKII), GLUT4 and PGC-1α. Insulin-stimulated glucose uptake was 39 
attenuated when cells were differentiated in the presence of insulin. In contrast, 40 
myotubes exposed to chronic insulin showed no alterations in phosphorylation of Akt 41 
Ser473. Both HKII and GLUT4 mRNA expression were reduced by chronic exposure 42 
to insulin; while PGC-1α was not different between culture conditions and was 43 
increased by acute insulin stimulation. These data suggest that there are differential 44 
responses in insulin signalling, transcription and glucose uptake of skeletal muscle 45 
cells when cultured in either the presence of insulin during differentiation or in 46 
myotube cultures.  47 
WORDS: 191 48 
 49 
 50 
 51 
  52 
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Introduction 53 
In healthy individuals, an increase in post-prandial blood glucose concentration leads 54 
to an increase in plasma insulin levels (Goodyear et al., 1996). This increase 55 
enables effective glucose disposal in insulin-sensitive tissues such as adipose, liver 56 
and skeletal muscle thus maintaining blood glucose homeostasis (Wasserman, 57 
2009). Skeletal muscle is responsible for the majority of post-prandial glucose uptake 58 
(DeFronzo et al., 1983), and a diminished response of skeletal muscle to insulin 59 
(insulin insensitivity) is a characteristic of metabolic diseases such as type II diabetes 60 
mellitus (Abdul-Ghani and Defronzo, 2010).  61 
In states of metabolic disease, skeletal muscle is continuously exposed to abnormal 62 
systemic concentrations of glucose, fatty acids, insulin and cytokines (Pendergrass 63 
et al., 1998; Zierath et al., 1998), Specifically, hyperinsulinemia’, has been 64 
considered both a consequence as well as driver of insulin resistance (Corkey, 2012), 65 
and can influence insulin signalling and glucose uptake in metabolic cells types such 66 
as adipocytes and skeletal muscle (Gonzalez et al., 2011; Kumar and Dey, 2003; 67 
Ricort et al., 1995). The precise mechanisms underpinning skeletal muscle insulin 68 
insensitivity in metabolic diseases is yet to be fully understood, however, the culture 69 
of skeletal muscle cells in vitro provides a system to understand cellular mechanisms 70 
regulating muscle adaptation and the pathogenesis of skeletal muscle insulin 71 
resistance, independent of the systemic environment (Aas et al., 2013). Various 72 
models of skeletal muscle insulin resistance have been developed using both cell 73 
lines and primary human cells (Aas et al., 2013; Jové et al., 2006; Nedachi et al., 74 
2008). Indeed, these in vitro cellular models have investigated the effects of a variety 75 
of factors such as pro-inflammatory cytokines, fatty acids and insulin upon skeletal 76 
muscle insulin signalling and glucose uptake (del Aguila et al., 2011; Jové et al., 77 
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2006; Kumar and Dey, 2003; Philp et al., 2010). In particular, exposure to high levels 78 
of insulin, as are common in metabolic disease states, have been reported to impair 79 
proximal insulin signalling in skeletal muscle cells (Kumar and Dey, 2003). 80 
Although progress has been made in establishing in vitro models of insulin resistant 81 
skeletal muscle, little attention has been paid to the potential influence of the 82 
myogenic programme. Both in vivo and in vitro, proliferating mononuclear myoblasts 83 
undergo myogenesis to form multinucleate terminally differentiated myotubes 84 
(Buckingham et al., 2003), characterised by elevations in the expression of the 85 
myogeninc regulatory factor Myogenin (Zammit, 2017). As such, two distinct phases 86 
exist whereby an insulin resistant muscle model could be established; either during 87 
myogeneis, such that the nascent myotubes are insulin resistant, or following 88 
myogenesis, where insulin resistance is induced in pre-existing myotube cultures. 89 
Indeed, although both methods have been used to investigate development of insulin 90 
insensitivity in muscle cells in vitro (del Aguila et al., 2011; Kumar and Dey, 2003), a 91 
consensus on the most suitable method for inducing this response is not currently 92 
clear. 93 
Therefore, the current experiments sought to determine if culture of skeletal muscle 94 
cells in the presence of insulin, which is a common symptom during the onset of 95 
insulin resistance and diabetes, would lead to disturbances in insulin-stimulated 96 
intracellular signalling, mRNA expression of key myogenic and metabolic genes and 97 
glucose uptake in C2C12 skeletal muscle cells. In this report, we show that 98 
myogenic cells cultured in the presence of insulin affects these cells more during 99 
myogenesis, whereas there were minimal effects of insulin exposure in post-mitotic 100 
skeletal muscle myotubes.   101 
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Methodology 102 
Cell Culture 103 
C2C12 myoblasts were grown using standard growth medium (GM) (Dulbecco’s 104 
Modified Eagle’s Medium (DMEM)) (Fisher –Scientific, Loughborough, UK), 20% 105 
fetal bovine serum (FBS) (Dutscher Scientific, EU approved, Essex UK), and, 1% 106 
Penicillin/Streptomycin (P/S) (Gibco, Invitrogen, Paisley, UK). Cells were harvested 107 
with the use of trypsin–EDTA (Sigma-Aldrich, Dorest, UK) at 80-90% confluence and 108 
subsequently counted using the trypan blue exclusion method and seeded at a 109 
density of 15,000 cellscm2 in 6 well plates. Conditions were conducted in triplicate 110 
wells and repeated across a minimum of three independent experiments. 111 
Exposure of differentiating myoblasts to insulin 112 
C2C12 myoblasts were grown to confluence before being changed to either a control 113 
differentiation media (CONTROL) (DMEM + 2% Horse Serum (HS) (Sigma-Aldrich, 114 
Dorset, UK)), or an insulin supplemented media (INSULIN) (DMEM + 2% HS and 115 
100 nM Insulin). Human recombinant insulin was purchased from Sigma-Aldrich 116 
(Sigma-Aldrich, Dorset, UK). Myoblasts were incubated in their respective medias for 117 
three days with the media changed twice daily as described previously (Kumar and 118 
Dey, 2003) (Figure 1a). The culture media was changed one hour prior to acute 119 
insulin stimulation. Cells were then washed twice in Krebs Ringer HEPES (KRH) 120 
buffer (10 mM HEPES pH 7.4, 138 mM NaCl, 4.7 mM KCl, 1.25 mM CaCl2, 1.25 mM 121 
MgSO, 5 mM Glucose and 0.05% BSA) and subsequently incubated twice in KRH 122 
buffer for 30 minutes before being stimulated for five minutes in KRH with insulin 123 
(100 nM) or left un-stimulated. Cells were then washed twice in PBS before being 124 
lysed for protein or RNA extraction. 125 
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Exposure of skeletal muscle myotubes to insulin 126 
C2C12 myoblasts were cultured until confluence, and differentiated in DM media for 127 
three days to encourage the formation of multinucleate myotubes. Subsets of wells, 128 
in triplicate, were acutely stimulated with insulin for five minutes prior to sampling for 129 
protein and RNA extraction (PRE). Further wells of myotubes, in triplicate, were 130 
either chronically treated with insulin (INSULIN) or kept in control DM for three days 131 
(CONTROL), prior to the acute five-minute insulin treatment as described above. 132 
Myotubes were sampled immediately following this acute insulin stimulation, for 133 
protein and RNA extraction. This protocol allowed for the examination of both basal 134 
chronic and acutely insulin-stimulated effects of chronic insulin treatment (Figure 1b). 135 
[INSERT FIGURE 1] 136 
Measurement of 3H-Deoxy-D-Glucose uptake. 137 
Glucose uptake was determined using 3H-Deoxy-D-Glucose (3H-2DG) as previously 138 
described (Nedachi and Kanzaki, 2006), with some slight modifications. Briefly, 139 
following 4 hr serum starvation, experimental plates (chronic treatments only) were 140 
washed twice in KRH buffer and incubated for 15 minutes in either the absence or 141 
presence of 100 nM insulin. Glucose uptake was determined by the addition of 3H-142 
Deoxy-D-Glucose (0.1 mM, 1µCimL; PerkinElmer Life and Analytical Science) for 30 143 
minutes. After incubation, cells were washed in PBS and lysed in 0.2 M Sodium 144 
Hydroxide (NaOH) in phosphate buffered saline (PBS). Glucose uptake was 145 
assessed by liquid scintillation counting (Pakard-Bell). Data was normalised to total 146 
protein collected from parallel experimental plates.  147 
Western Blotting 148 
Cells were homogenised in lysis buffer (50 mM HEPES, 150 mM NaCl, 1.5 mM 149 
MgCl2, 1 mM EGTA, 50 mM NaF, 50 mM β-Glycerophosphate, 1 mM Na3VO4, 1% 150 
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Triton X-100, 2 mM PMSF) and protein content of the samples was determined using 151 
the Pierce 660nm protein assay (Thermo-Fisher, Loughborough, UK). Prior to 152 
analysis, samples were mixed in Laemmli buffer (4 mL H2O, 1mL 1M TRIS HCl pH 153 
6.8, 0.4mL Glycerol, 0.4mL 2-β-mercaptoethanol, 0.05% bromophenol blue), and 154 
boiled for 5 minutes at 95ºC. Thereafter, 20µg of protein per sample was loaded into 155 
SDS-polyacrylamide gels (4% stacking and 12% resolving) for separation by 156 
electrophoresis (SDS-PAGE). Proteins were then wet transferred on to nitrocellulose 157 
membranes (Whatman Proton, Sigma-Aldrich, Dorset, UK), for 2 hr at a constant 158 
current of 0.35 Amps. Membranes were blocked for 1h with bovine serum albumin 159 
(BSA) (Sigma-Aldrich, Do set, UK) at 4ºC and rinsed three times in Tris Buffered 160 
Saline with Tween (Tris, NaCl, pH 7.4, Tween-20, TBST), before being incubated 161 
with primary antibody overnight at 4ºC. Primary antibodies used in the experiments 162 
were, Akt, phospho Akt (Ser473) and β-Actin (Cell Signalling, MA, USA). Following 163 
overnight primary antibody incubation, membranes were washed in TBST and 164 
subsequently incubated with anti-rabbit horseradish peroxidase-conjugated 165 
secondary antibody (Cell Signalling, MA, USA). Proteins were visualised using 166 
chemiluminescence substrate (Supersignal, ThermoFisher Scientific, Rockford, IIL, 167 
USA) and band densities were quantified using Quantity One image analysis 168 
software (Quality One 1-D analysis software version 4.6.8).  Phosphorylation of 169 
proteins was normalised to the respective total protein and a housekeeping protein 170 
(β-Actin).   171 
RNA extraction and qPCR analysis 172 
RNA was extracted using TRI Reagent (Sigma-Aldrich, Dorset, UK) according to 173 
manufacturer’s instructions and concentrations (ng/µL) and purity of RNA samples 174 
were determined using UV spectroscopy (NanoDrop, Fisher Scientific, 175 
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Loughborough, UK). Gene expression was analysed by One-step reverse 176 
transcription-PCR using a Stratagene Mx3005p thermocycler (Agilent Technologies 177 
LDA UK Limited, Cheshire, UK). Primer sequences were synthesised by Sigma 178 
Aldrich (Sigma-Aldrich, Dorset, UK) as shown in Table 1. Each reaction consisted of 179 
70 ng of RNA diluted in 9.5µL of nuclease free water, 0.15 µL forward primer, 0.15 180 
µL reverse primer (100 µM), 10 µL Quantifast SYBR Green Mix (Qiagen, Crawley, 181 
UK) and 0.2 µL of reverse transcriptase (RT)-Mix (Qiagen, Crawley, UK) to constitute 182 
a final 20 µL reaction volume (Qiagen Chemistries, Crawley, UK). RT-PCR was 183 
conducted using the following steps: 10 min hold at 50 °C (reverse transcription), 184 
followed by a 5 min hold at 95 °C, and cycling between 95 °C for 10 s (denaturation) 185 
and 60 °C for 30 s (annealing and extension). Fluorescence was detected after every 186 
cycle (40 cycles) and data was analysed using the ∆∆CT method using RNA 187 
polymerase II beta (POLR2B) as an endogenous control gene. 188 
[INSERT TABLE 1] 189 
 190 
Statistical Analysis 191 
Data is presented as Mean ± S.E.M. Differences between conditions were analysed 192 
by ANOVA with post-hoc Bonferroni using SPSS (IBM SPSS, Version 19, NY, USA). 193 
When variances between conditions were found to be significant, Welch’s F ratio 194 
was used to analyse significance with post-hoc Games-Howell to show differences 195 
between conditions. Significance level was set at equal to or less than p < 0.05.  196 
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Results 197 
3H-Deoxy-D-Glucose uptake following acute and chronic insulin exposure in 198 
differentiating myoblasts and skeletal muscle myotubes 199 
 200 
Firstly, the effect of chronic insulin treatment on insulin stimulated glucose uptake 201 
was investigated in C2C12 cells during myogenesis or in pre-existing myotubes.As 202 
expected, skeletal muscle cells differentiated in control media showed a significant 203 
increase in glucose uptake when stimulated with insulin for 30 minutes compared to 204 
basal control (p <0.05) (Figure 2a). However, this response was not replicated in 205 
myoblasts differentiated in the presence of insulin (p >0.05), which were found to 206 
have an increased basal level of glucose uptake. This increase in basal uptake was 207 
significantly greater than the basal uptake in myoblasts differentiated in control 208 
conditions (p < 0.01), suggesting that chronically elevated levels of insulin in this 209 
system results in elevated basal glucose uptake, independent of the action of 210 
exogenous insulin (Figure 2a). What is more there was no added effect of acute 211 
insulin stimulation upon glucose uptake following differentiation in the presence of 212 
insulin (p > 0.05).  213 
Glucose uptake in skeletal muscle myotubes was analysed following differentiation 214 
and following culture in the presence of insulin (Figure 2b). Despite small increases 215 
in glucose uptake, there was no significant difference between basal and insulin 216 
stimulated myotubes differentiated for 3 days (PRE) (p >0.05). Similarly, myotubes 217 
cultured in control media for a further 3 days (CONTROL) showed a small increase 218 
in glucose uptake following acute insulin stimulation compared to basal conditions 219 
however this was not statistically significant (p >0.05).  In myotubes cultured in the 220 
presence of insulin (INSULIN), there was an increase in basal uptake, similar to that 221 
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observed in skeletal muscle cells differentiated in the presence of insulin, however 222 
the differences between conditions, and the effect of acute insulin stimulation, were 223 
not found to have any significant effect (p > 0.05). 224 
 225 
[INSERT FIGURE 2] 226 
  227 
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The effects of chronic insulin exposure on Akt Ser473 phosphorylation in 228 
myoblasts during differentiation. 229 
 230 
To investigate the effect of insulin exposure on intracellular signalling proteins, 231 
expression of the phosphorylated Akt Ser473 was analysed due to its central role in 232 
recruitment of downstream insulin signalling proteins. Myoblast differentiation in the 233 
presence of insulin had a significant main effect upon the phosphorylation of Akt 234 
Ser473 (p < 0.05, Figure 3). Acute insulin stimulation increased the phosphorylation of 235 
Akt Ser473 compared to basal levels in skeletal muscle cells differentiated in control 236 
media (p < 0.05, Figure 3). However, stimulation with insulin did not increase 237 
phosphorylated Akt Ser473 in cells differentiated in the presence of insulin (p > 0.05, 238 
Figure 3), which remained similar to basal levels in the control untreated condition (p > 239 
0.05, Figure 3b). This suggests that three days of insulin treatment throughout the 240 
differentiation period, contributes towards a reduced capacity for Akt Ser473 241 
phosphorylation by acute insulin stimulation, compared to myoblasts differentiated in 242 
normal DM conditions.  243 
[INSERT FIGURE 3] 244 
 245 
mRNA expression in response to acute and chronic insulin exposure in 246 
skeletal muscle cells during myogenesis. 247 
 248 
In order to investigate how the differences in insulin signalling between conditions 249 
had an effect upon transcriptional markers, the mRNA expression of genes which 250 
play a role in metabolism and myogenesis were analysed. Acute stimulation with 251 
insulin, significantly increased HKII mRNA expression in cells cultured in control 252 
media (p <0.01), however no change was observed in myoblasts differentiated in the 253 
Page 11 of 31
John Wiley & Sons, Inc.
Journal of Cellular Biochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
12 
 
presence of insulin (p > 0.05, Figure 4). GLUT4 mRNA expression reduced following 254 
acute insulin stimulation in skeletal muscle cells differentiated in control media (p < 255 
0.05). Cells differentiated in the presence of insulin were found to express lower 256 
GLUT4 mRNA expression, compared to the expression in cells cultured in control 257 
media (p < 0.05, Figure 4) which was not affected by acute insulin stimulation. In 258 
contrast, PGC-1α mRNA expression was different between conditions (p < 0.01), 259 
increasing following acute insulin stimulation in cells cultured in control media to a 260 
level which approached significance (p = 0.07), whereas there was no difference in 261 
PGC-1α mRNA expression as a result of acute insulin stimulation in skeletal muscle 262 
cells differentiated in the presence of insulin (p > 0.05, Figure 4). In addition to 263 
investigating metabolic genes, the effect of insulin exposure on the myogenic 264 
transcription factor, myogenin, was investigated, as it is a pivotal regulator of skeletal 265 
muscle differentiation. Myoblasts differentiated in control media showed an increase 266 
in myogenin mRNA expression (p < 0.05), compared to basal when stimulated with 267 
insulin. In contrast, culture with insulin resulted in lower expression of myogenin 268 
mRNA when stimulated with insulin, compared to basal when differentiated in the 269 
presence of insulin (p < 0.05, Figure 4). This would suggest that acute insulin 270 
stimulation can induce changes in the mRNA expression of metabolic genes and 271 
subsequent culture in the presence of insulin can attenuate the induction of these 272 
genes by acute insulin stimulation. In contrast, myogenin expression is influence 273 
more by chronic culture in insulin rather than acute insulin stimulation.  274 
[INSERT FIGURE 4] 275 
  276 
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The effects of acute and chronic insulin exposure on the expression of key 277 
signalling proteins in post-mitotic skeletal muscle myotubes. 278 
 279 
After three days differentiation, acute insulin stimulation significantly increased the 280 
phosphorylation of Akt Ser473 compared to basal levels (p < 0.05). Myotubes cultured 281 
in control media for a further three days also increased phosphorylation of Akt Ser473 282 
as a result of insulin stimulation compared to basal control; however, the differences 283 
between the basal control and insulin stimulation were not significantly different (p > 284 
0.05). In contrast, myotubes cultured in the presence of insulin showed no changes 285 
in phosphorylated Akt Ser473 between basal and acute insulin stimulation (p > 0.05) 286 
(Figure 5). Together this suggests that, acute insulin stimulation was not effective in 287 
significantly inducing phosphorylation Akt in skeletal muscle myotubes cultured in 288 
control media or in the presence of insulin.   289 
[INSERT FIGURE 5] 290 
  291 
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mRNA expression of metabolic and myogenic markers in response to acute 292 
and chronic insulin exposure in skeletal muscle myotubes. 293 
 294 
In myotube cultures, a significant main effect was observed in HKII mRNA 295 
expression (p <0.05). Myotubes which were cultured in the presence of insulin 296 
showed a reduction in expression of HKII compared to differentiated myotubes (p < 297 
0.05) (Figure 6), with a similar response observed for GLUT4 mRNA expression (p < 298 
0.05) (Figure 6). Acute insulin stimulation had no effect upon HKII or GLUT4 mRNA 299 
expression in any of the conditions over basal control (p > 0.05), but acute insulin did 300 
significantly increase mRNA expression of PGC-1α (p < 0.05), independent of 301 
condition (p > 0.05) (Figure 6). Myogenin mRNA expression showed no significant 302 
main effects for culture condition or acute insulin stimulation (p > 0.05); however, 303 
there was a significant interaction effect (p < 0.05). Acute insulin stimulation 304 
significantly increased myogenin expression in differentiated skeletal muscle 305 
myotubes (p < 0.05), although this effect was not observed in myotubes cultured in 306 
control media (p > 0.05). There was however, a trend for a reduction in myogenin 307 
expression following acute insulin stimulation in myotubes cultured in the presence 308 
of insulin (p = 0.06) (Figure 6), demonstrating a divergent response in the early and 309 
late myotube conditions.  310 
 [INSERT FIGURE 6] 311 
  312 
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Discussion 313 
Insulin stimulates glucose uptake in a wide variety of cell types and contributes to a 314 
number of other cellular functions however, insulin stimulated glucose disposal is 315 
highest in metabolic tissues such as skeletal muscle (DeFronzo et al., 1983). Despite 316 
of the fact that insulin-mediated glucose utilisation is high in metabolic tissues such 317 
as skeletal muscle, continuous exposure to elevated levels of insulin, such that occur 318 
in metabolic diseases, can have negative effects on cellular metabolism (Kumar and 319 
Dey, 2003; Pagel-Langenickel et al., 2008). The development of in vitro models of 320 
skeletal muscle insulin resistance are undoubtedly useful tools for defining the 321 
underpinning mechanisms, and as such the most suitable methods to induce this 322 
phenotype should be explored.  323 
Using a model of hyperinsulinemia to induce insulin resistance, we investigated the 324 
impact of exposure to insulin during myogenesis of skeletal muscle cells and in 325 
differentiated skeletal muscle myotubes. Our results indicate that insulin stimulated 326 
glucose uptake was altered as a result of exposure to insulin during myogenesis. 327 
Similar responses have been observed previously in C2C12 skeletal muscle cells 328 
using a similar model of hyperinsulineamic induced insulin resistance (Kumar and 329 
Dey, 2003, 2002). The similar findings between our work and those of Kumar and 330 
Dey provides validation of the use of this method of exposing skeletal muscle cells to 331 
insulin during myogenesis for induction of insulin insensitivity. To see if the findings 332 
could be translated into skeletal muscle myotubes, we next investigated the method 333 
in inducing skeletal muscle insulin resistance following myogenic differentiation. 334 
While the trends were similar to those observed in skeletal muscle cells during 335 
myogenesis, the changes were not significant, suggesting that the changes in 336 
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glucose uptake following hyperinsulinemic induced insulin resistance were more 337 
prominent during the differentiation of skeletal muscle cells.  338 
In order to investigate the impact of the changes in glucose uptake which were 339 
observed, analysis of the phosphorylation of Akt (Ser473) was investigated. Acute 340 
insulin stimulation significantly augmented Akt phosphorylation in skeletal muscle 341 
cells following myogenesis; however, phosphorylation of Akt was not increased 342 
following acute insulin stimulation following chronic culture in control or insulin media 343 
during cell differentiation. Often an indicator of insulin signalling activation, impaired 344 
Akt phosphorylation is attenuated in insulin resistant skeletal muscle (Karlsson et al., 345 
2005). Other in vitro research in skeletal muscle and adipocyte cells has reported 346 
impaired proximal insulin signalling, specifically at the site of the insulin receptor, in a 347 
model of hyperinsulineamic induced insulin resistance (Kumar and Dey, 2003; Ricort 348 
et al., 1995). Therefore, the changes in Akt phosphorylation observed in skeletal 349 
muscle cells following insulin exposure are most likely a result of impaired signalling 350 
upstream of Akt.  351 
In order to further characterise the model of hyperinsulinemia induce insulin 352 
resistance in skeletal muscle, important genes involved in metabolism, which are 353 
differentially expressed in states of insulin resistance were analysed (Ducluzeau et 354 
al., 2001). Hexokinase II is important in metabolic regulation and can be seen as a 355 
potential bio-marker of insulin resistance, due to the reduction in expression 356 
observed in skeletal muscle of insulin resistant subjects (Mandarino et al., 1995; 357 
Pendergrass et al., 1998; Vestergaard et al., 1995). While skeletal muscle cells 358 
differentiated in the presence of insulin showed an attenuated response in HKII 359 
mRNA expression following acute insulin stimulation, skeletal muscle myotubes did 360 
not respond in a similar manner. Insulin has been shown to act as a regulator of HKII 361 
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mRNA expression in skeletal muscle (Printz et al., 1993), specifically through a PI-3 362 
kinase dependent pathway (Osawa et al., 1996).  363 
The transcriptional coactivator PGC1alpha appears to play a key role in energy 364 
metabolism (Wu et al., 2016). Overexpression of PGC1alpha increases GLUT4 365 
expression and glucose uptake in skeletal muscle (Benton et al., 2008) whereas its 366 
deletion leads to abnormal glucose homeostasis (Handschin and Spiegelman, 2006). 367 
The reduction in PGC-1α mRNA expression in response to chronic exposure to 368 
insulin in differentiating skeletal muscle cells was somewhat expected based on 369 
Akt’s role in mediating Foxo1 localisation with PGC1 in the nucleus (Brunet et al., 370 
1999; Fernandez-Marcos and Auwerx, 2011). This finding lends further support to 371 
the notion that this method represents a strong model for inducing insulin resistance 372 
since PGC1 alpha levels are attenuated in diabetic skeletal muscle. In contrast, the 373 
increase in PGC1alpha in response to acute insulin stimulation in both differentiating 374 
control cells and pre-existing myotubes regardless of chronic insulin treatment was 375 
surprising. Ling and colleagues have previously observed an increase in PGC1alpha 376 
mRNA levels following a hyperinsulinaemic euglycaemic clamp in young and elderly 377 
twins (Ling et al., 2004), however the mechanisms which underpin this observation 378 
are not well understood and are beyond the scope of the present investigation. 379 
Interestingly however, in our study, the transcription of PGC1alpha in myoblasts 380 
differentiated in the presence of insulin was impaired, further suggesting that 381 
metabolic control is somewhat supressed with this intervention. 382 
In the current set of experiments, differentiating myoblasts but not myotubes, 383 
showed a reduction in GLUT4 mRNA expression following chronic exposure to 384 
insulin. The repression of GLUT4 mRNA transcription is a common physiological 385 
response following response exposure to a hyperinsulinemic environment in insulin 386 
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sensitive tissues (Flores-Riveros et al., 1993), leading to a reduction in insulin 387 
stimulated glucose uptake. Importantly hyperinsulinaemia has been shown to 388 
diminish GLUT4 translocation upon insulin stimulation and increased basal glucose 389 
uptake in L6 skeletal muscle cells exposed to high glucose and insulin (Huang et al., 390 
2002). In addition, although not measured in our experiments, other glucose 391 
transporters such as GLUT1 have been reported to increase following prolonged 392 
exposure to insulin (Taha et al., 1999). This change in glucose transporter 393 
expression could explain the increased basal uptake observed in C2C12 skeletal 394 
muscle cells cultured in the presence of insulin during differentiation and to an extent, 395 
in differentiated myotubes.  396 
In conclusion, these experiments show that alterations in glucose uptake, insulin 397 
signalling, and gene transcription were affected by exposure to insulin during 398 
differentiation. This therefore describes a putative model of hyperinsulineamic 399 
induced skeletal muscle cell insulin resistance. This contrasts with the effects of 400 
hyperinsulineamia on post-mitotic skeletal myotube cultures, myotubes, where by 401 
alterations in gene transcription and glucose uptake were not characteristic of an 402 
insulin resistant phenotype. Therefore, based on our findings and the biomarkers 403 
used as indicators of potential insulin resistance (Table 2), skeletal muscle cells 404 
exposed to insulin during differentiation appears to be an effective method for the 405 
development of a hyperinsulinemia-induced insulin resistant skeletal muscle. This 406 
model has potential to be used as a method for inducing skeletal muscle insulin 407 
resistance in vitro, which could be used to investigate potential lifestyle interventions 408 
such as exercise, upon insulin resistant skeletal muscle.  409 
[INSERT TABLE 2]  410 
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Figure Legends 537 
Figure 1. Protocol schematic for investigating chronic insulin exposure upon A; 538 
skeletal muscle cells during myogenesis and B; post-mitotic skeletal muscle 539 
myotubes.  540 
Figure 2. A; 3H-Deoxy-D-Glucose uptake in C2C12 skeletal muscle cells during 541 
myogenesis.B C2C12 skeletal muscle myotubes. Skeletal muscle myotubes were 542 
exposed to low serum media supplemented without (Control) or with (Insulin) the 543 
addition of insulin (100 nM). Open bars represent unstimulated filled bars 544 
represented acute 30 minutes insulin stimulation. * Significantly different to control 545 
(p<0.05). † Significantly different to control unstimulated (p<0.05). * Significantly 546 
different from control unstimulated sample (p<0.05). 547 
Figure 3. Akt (Ser473) phosphorylation following insulin exposure in C2C12 skeletal 548 
muscle cells during myogenesis. Open bars represent unstimulated filled bars 549 
represented acute 30 minutes insulin stimulation. * Significantly different to control 550 
(p<0.05). † Significantly different to control unstimulated (p<0.05).  551 
Figure 4. Gene expression analysis (∆∆Ct) of C2C12 skeletal muscle cells 552 
differentiated in control media (CON) or chronically exposed to insulin (100 nM) (IT). 553 
A; GLUT4, B; HKII, C; PGC-1α, D; MyoG. Open bars represent unstimulated filled 554 
bars represented acute 30 minutes insulin stimulation. * Significantly different from 555 
control unstimulated sample (p<0.05).  556 
Figure 5. Akt (Ser473) phosphorylation C2C12 skeletal muscle myotubes following 557 
differentiation (PRE), control media (CON) or chronically exposed to insulin (100 nM) 558 
(IT). Open bars represent unstimulated filled bars represented acute 30 minutes 559 
insulin stimulation. * Significantly different to control (p<0.05). † Significantly different 560 
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to control unstimulated (p<0.05). * Significantly different from control unstimulated 561 
sample (p<0.05).   562 
Figure 6. Gene expression analysis (∆∆Ct) of C2C12 skeletal muscle myotubes 563 
following differentiation (PRE) and chronic incubation in control media (CON) or high 564 
insulin (100 nM) media (IT). A; GLUT4, B; HKII, C; PGC-1α, D; MyoG. Open bars 565 
represent unstimulated filled bars represented acute 30 minutes insulin stimulation. # 566 
significantly different to unstimulated sample (p<0.05). * Significantly different to pre-567 
unstimulated sample (p<0.05). § Significantly different to Pre (p<0.05). 568 
 569 
Table Legend 570 
Table 1. Primer sequences of mouse mRNA genes used for one-step qPCR 571 
Table 2. Summary of findings in skeletal muscle cells during myogenesis 572 
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Figure 1. Protocol schematic for investigating chronic insulin exposure upon A; skeletal muscle cells during 
myogenesis and B; post-mitotic skeletal muscle myotubes.  
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Figure 2. A; 3H-Deoxy-D-Glucose uptake in C2C12 skeletal muscle cells during myogenesis.B C2C12 skeletal 
muscle myotubes. Skeletal muscle myotubes were exposed to low serum media supplemented without 
(Control) or with (Insulin) the addition of insulin (100 nM). Open bars represent unstimulated filled bars 
represented acute 30 minutes insulin stimulation. * Significantly different to control (p<0.05). † Significantly 
different to control unstimulated (p<0.05). * Significantly different from control unstimulated sample 
(p<0.05).  
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Figure 3. Akt (Ser473) phosphorylation following insulin exposure in C2C12 skeletal muscle cells during 
myogenesis. Open bars represent unstimulated filled bars represented acute 30 minutes insulin stimulation. 
* Significantly different to control (p<0.05). † Significantly different to control unstimulated (p<0.05).  
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Figure 4. Gene expression analysis (∆∆Ct) of C2C12 skeletal muscle cells differentiated in control media 
(CON) or chronically exposed to insulin (100 nM) (IT). A; GLUT4, B; HKII, C; PGC-1α, D; MyoG. Open bars 
represent unstimulated filled bars represented acute 30 minutes insulin stimulation. * Significantly different 
from control unstimulated sample (p<0.05).  
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Figure 5. Akt (Ser473) phosphorylation C2C12 skeletal muscle myotubes following differentiation (PRE), 
control media (CON) or chronically exposed to insulin (100 nM) (IT). Open bars represent unstimulated filled 
bars represented acute 30 minutes insulin stimulation. * Significantly different to control (p<0.05). † 
Significantly different to control unstimulated (p<0.05). * Significantly different from control unstimulated 
sample (p<0.05).    
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Figure 6. Gene expression analysis (∆∆Ct) of C2C12 skeletal muscle myotubes following differentiation (PRE) 
and chronic incubation in control media (CON) or high insulin (100 nM) media (IT). A; GLUT4, B; HKII, C; 
PGC-1α, D; MyoG. Open bars represent unstimulated filled bars represented acute 30 minutes insulin 
stimulation. # significantly different to unstimulated sample (p<0.05). * Significantly different to pre-
unstimulated sample (p<0.05). § Significantly different to Pre (p<0.05).  
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Table 1 Primer Sequences of mouse mRNA used for one-step PCR 
 
 
 
 
 
 
 
 
 
 
Gene Primer Sequence Accession No: 
RNA Polymerase II -Beta (POLR2B ) F: 5’-GGTCAGAAGGGAACTTGTGGTAT 
R: 5’-GCATCATTAAATGGAGTAGCGTC 
NM_153798 
Myogeninn (MyoG) F: CCAACTGAGATTGTCTGTC  
R: GGTGTTAGCCTTATGTGAAT  
NM_031189 
Peroxisome Proliferator-Activated coactivator (PGC1-α) F: 5’-AGACTATTGAGCGAACCT 
R: 5’-TATGAGGAGGAGTTGTGG 
NM_008904.2 
Hexokinase II (HKII) F: 5’- GGAGGAGGAGCAGTATGG 
R: 5’-TTCAGCCGTGTGAGGTAA 
NM_013820 
GLUT4 F: 5’-CATCAGGATAAACAGCAGGG  
R: 5’-GGAGGCAGGGCTAGATTT 
NM_011480 
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Table 2 Findings summary 
Findings Summary 
• Chronic exposure to insulin impaired phosphorylation of insulin signalling proteins in differentiating skeletal 
muscle cells. 
• The mRNA expression of metabolic genes was impaired following acute stimulation in differentiating skeletal 
muscle cells chronically exposed insulin. 
• Basal glucose uptake in differentiating skeletal muscle cells was increased following chronic insulin exposure. 
This increase hindered any observation of insulin stimulated glucose uptake in these cultures. 
• Acute insulin stimulation did not change mRNA expression of skeletal muscle myotubes. 
• Chronic insulin exposure increased GLUT4 mRNA expression while reducing HKII mRNA expression. 
• Chronic insulin exposure in skeletal muscle myotubes did not alter insulin stimulated glucose uptake. 
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